JOURNAL OF BUON, vol.24, no.1, pp.242-248, 2019 (Peer-Reviewed Journal)
Article / Article
JOURNAL OF BUON
Science Citation Index Expanded, Scopus
Purpose: To compare the efficacy and adverse effect profiles of the first-line treatment of patients with KRAS wild type metastatic colorectal cancer (CRC) in Turkey who were treated based on regimens including bevacizumab, cetuximab and panitumumab.